Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03824145 · ClinicalTrials.gov registry record · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
A NA study of Metastatic Breast Cancer, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- NA
- Development phase
- 176
- Enrollment target
- 2
- Study locations
NCT03824145 is a NA study of Metastatic Breast Cancer that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 176 participants, below the 204-participant average among 139 other Metastatic Breast Cancer trials with a reported enrollment target (14% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03824145, a NA study of Metastatic Breast Cancer, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- NA
- Development phase
- 176 participants
- Enrollment target
- 2
- Study locations
Study Summary
This multi-site study is being conducted to examine dietary and activity patterns, body composition, blood and quality of life in breast cancer patients. The study will recruit 176 women with MBC in Milwaukee (n=88) and Chicago (n=88).
Conditions Studied
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL Lifestyle Intervention
Study Locations (2)
Illinois
- Loyola University - Maywood
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03824145
The ClinicalTrials.gov registry entry for NCT03824145 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 204-participant average among 139 other Metastatic Breast Cancer trials with a reported enrollment target (14% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metastatic Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.
NCT03824145 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03824145 about?
NCT03824145 is a clinical study titled "Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer". This multi-site study is being conducted to examine dietary and activity patterns, body composition, blood and quality of life in breast cancer patients. The study will recruit 176 women with MBC in Milwaukee (n=88) and Chicago (n=88).
What is the current status of trial NCT03824145?
This trial is currently recruiting. It is a NA study. The enrollment target is 176 participants. The study started on 2022-11-01. Estimated completion is 2027-02-01.
What conditions does trial NCT03824145 study?
This clinical trial studies the following conditions: Metastatic Breast Cancer.
What interventions are being tested in trial NCT03824145?
The interventions under investigation include: Attention Control (BEHAVIORAL), Lifestyle Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03824145?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03824145 being conducted?
This trial has 2 study locations across Illinois, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer
RECRUITING · NA
-
Adaptation of a Values Assessment Tool
RECRUITING · NA
-
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
RECRUITING · NA
-
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
RECRUITING · NA
-
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
RECRUITING · NA
-
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.